CR8823A - Metodos y composiciones para la cicatrizacion de heridas - Google Patents

Metodos y composiciones para la cicatrizacion de heridas

Info

Publication number
CR8823A
CR8823A CR8823A CR8823A CR8823A CR 8823 A CR8823 A CR 8823A CR 8823 A CR8823 A CR 8823A CR 8823 A CR8823 A CR 8823A CR 8823 A CR8823 A CR 8823A
Authority
CR
Costa Rica
Prior art keywords
methods
compositions
devices
cicatrization
wound
Prior art date
Application number
CR8823A
Other languages
English (en)
Inventor
Chandan K Sen
Original Assignee
Univ Ohio State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ohio State Res Found filed Critical Univ Ohio State Res Found
Publication of CR8823A publication Critical patent/CR8823A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Metodos, dispositivos y composiciones para tratar lesiones en animales, que comprenden perxido de hidrogeno en concentraciones que son menores a las usada convencionalmente. Los metodos, dispositivos y composiones aceleran l acicatrizacion de heridas.
CR8823A 2004-06-18 2006-12-18 Metodos y composiciones para la cicatrizacion de heridas CR8823A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/871,158 US20050281890A1 (en) 2004-06-18 2004-06-18 Methods and compositions for wound healing

Publications (1)

Publication Number Publication Date
CR8823A true CR8823A (es) 2008-03-18

Family

ID=35480874

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8823A CR8823A (es) 2004-06-18 2006-12-18 Metodos y composiciones para la cicatrizacion de heridas

Country Status (16)

Country Link
US (1) US20050281890A1 (es)
EP (1) EP1765368A4 (es)
JP (1) JP2008503485A (es)
KR (1) KR20070042927A (es)
CN (1) CN101022816A (es)
AP (1) AP2007003872A0 (es)
AU (1) AU2005265115A1 (es)
BR (1) BRPI0510925A (es)
CA (1) CA2580381A1 (es)
CR (1) CR8823A (es)
EA (1) EA200700074A1 (es)
EC (1) ECSP077153A (es)
GB (1) GB2434983B (es)
IL (1) IL180128A0 (es)
WO (1) WO2006009853A1 (es)
ZA (1) ZA200610781B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5366553B2 (ja) 2005-11-09 2013-12-11 クロックス テクノロジーズ インコーポレイテッド 歯のホワイトニング組成物及び方法
US8338402B2 (en) 2006-05-12 2012-12-25 Smith & Nephew Plc Scaffold
CA2652007C (en) * 2006-05-12 2015-10-13 Smith & Nephew Plc Scaffold
WO2007134304A1 (en) * 2006-05-15 2007-11-22 Virginia Commonwealth University Methods and compositions for controlled and sustained production and delivery of peroxides
US20100266989A1 (en) 2006-11-09 2010-10-21 Klox Technologies Inc. Teeth whitening compositions and methods
ZA200801723B (en) * 2007-02-23 2009-07-29 Univ Witwatersrand Jhb A polyamide rate-modulated monolithic drug delivery system
CA2682507C (en) 2007-04-09 2017-11-21 Wake Forest University Health Sciences Oxygen-generating compositions for enhancing cell and tissue survival in vivo
US20090202617A1 (en) * 2008-02-13 2009-08-13 Ward Kevin R Gas based wound and tissue therapeutics
AU2009271530B2 (en) * 2008-07-18 2016-01-07 Oxygen Biotherapeutics, Inc. Method of treating traumatic brain injury
NZ592651A (en) * 2008-11-07 2013-05-31 Klox Technologies Inc Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin
US8343515B2 (en) 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
PL2453922T3 (pl) 2009-07-17 2018-03-30 Klox Technologies Inc. Przeciwbakteryjna doustna kompozycja
US20110086923A1 (en) * 2009-07-28 2011-04-14 Thompson Deborah P Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons
US8778387B2 (en) * 2009-09-02 2014-07-15 Hyprotek, Inc. Antimicrobial medical dressings and protecting wounds and catheter sites
CA2786880C (en) 2010-01-22 2018-04-24 Hyprotek, Inc. Antimicrobial agents and methods of use
US8513309B2 (en) 2010-10-01 2013-08-20 Oxygen Biotherapeutics, Inc. Perfluorocarbons for use in treating pruritus
US9039967B2 (en) 2012-02-06 2015-05-26 Hyprotek, Inc. Antiseptic applicators and packaging techniques
US20130281913A1 (en) 2012-04-20 2013-10-24 Klox Technologies Inc. Biophotonic compositions and methods for providing biophotonic treatment
US11116841B2 (en) 2012-04-20 2021-09-14 Klox Technologies Inc. Biophotonic compositions, kits and methods
EP2895139B1 (en) 2012-09-14 2019-10-23 Bausch Health Companies Inc. Methods for teeth whitening
US20140276354A1 (en) 2013-03-14 2014-09-18 Klox Technologies Inc. Biophotonic materials and uses thereof
HK1219890A1 (zh) 2013-07-03 2017-04-21 广东科洛克生物医药集团有限公司 治疗不癒合伤口的组合物和方法
JP2017509433A (ja) 2014-04-01 2017-04-06 クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． 組織充填剤組成物および使用方法
RU2017117187A (ru) 2014-10-31 2018-11-30 Клокс Текнолоджиз Инк. Фотоактивируемые волокна и тканые материалы
WO2016187093A1 (en) * 2015-05-15 2016-11-24 Garcia Carlos Diego Scent control compositions
CN106376423A (zh) * 2016-08-28 2017-02-08 铜仁市万山区山地葡萄科技有限公司 一种葡萄树伤流的救治方法
JP2023551063A (ja) * 2020-12-01 2023-12-06 カステラーナ，ロッサーナ 皮膚及び粘膜の外傷性病変を治癒するための製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163800A (en) * 1977-08-17 1979-08-07 The Procter & Gamble Company Topical composition and treatment of skin lesions therewith
GB9225581D0 (en) * 1992-12-08 1993-01-27 Courtaulds Plc Wound dressings
US6833408B2 (en) * 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
US6592907B2 (en) * 1999-10-04 2003-07-15 Hampar L. Karagoezian Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
EP1244476B1 (en) * 1999-12-30 2006-05-31 Acrymed Methods and compositions for improved delivery devices
EP1353679A2 (en) * 2001-01-22 2003-10-22 Randolph M. Howes Compositions, methods and apparatuses for singlet oxygen delivery
US20060134186A1 (en) * 2002-03-28 2006-06-22 Carlton Richard M Oxygenating agents for enhancing host responses to microbial infections
US6949240B2 (en) * 2002-05-23 2005-09-27 The Procter & Gamble Company Tooth whitening products
US20040001878A1 (en) * 2002-06-26 2004-01-01 Deroyal Industries, Inc. Infused wound care dressings
US8956160B2 (en) * 2002-07-02 2015-02-17 Ranir, Llc Device and method for delivering an oral care agent

Also Published As

Publication number Publication date
ECSP077153A (es) 2007-04-26
AP2007003872A0 (en) 2007-02-28
EP1765368A4 (en) 2010-06-02
WO2006009853A1 (en) 2006-01-26
CA2580381A1 (en) 2006-01-26
GB2434983B (en) 2009-01-28
AU2005265115A1 (en) 2006-01-26
GB2434983A (en) 2007-08-15
KR20070042927A (ko) 2007-04-24
US20050281890A1 (en) 2005-12-22
IL180128A0 (en) 2007-06-03
JP2008503485A (ja) 2008-02-07
EP1765368A1 (en) 2007-03-28
HK1103642A1 (zh) 2007-12-28
ZA200610781B (en) 2010-05-26
EA200700074A1 (ru) 2007-08-31
GB0700356D0 (en) 2007-02-14
BRPI0510925A (pt) 2007-11-13
CN101022816A (zh) 2007-08-22

Similar Documents

Publication Publication Date Title
ECSP077153A (es) Métodos y composiciones para la cicatrización de heridas
CR9869A (es) Compuestos activos en ppar
SG158153A1 (en) Compositions and methods for promoting wound healing and tissue regeneration
AR018674A1 (es) Aparato para tratar un volumen particular de tejido vegetal o animal que contiene por lo menos un agente.
MX346450B (es) Composiciones y métodos para el tratamiento de la enfermedad celíaca.
BRPI0618086A8 (pt) Método, aparelho, produto de programa de computador e dispositivo para programação de transmissão de dados para melhorar a eficiência do consumo de potência em uma rede sem fio
IL249263B (en) Method for ex-vivo organ care
CY1118624T1 (el) Συνθεσεις οι οποιες περιεχουν μελι και ενα υπεραπορροφητικο υλικο
ATE407967T1 (de) Nukleierungsmittel
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
CU20070261A7 (es) Compuestos de motilida
MA28707B1 (fr) Utilisation de 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines substituees lors du traitement de nausees et de vomissements
PA8597501A1 (es) Derivados azabiciclicos de piridiloximetilo y bencisoxazol
CY1112607T1 (el) Εντομοκτονοι συνδυασμοι που περιλαμβανουν αβαμεκτινη και κυφλουμετοφενη
WO2013070670A8 (en) Device for tendon and ligament treatment
GT201000175A (es) Uso de derivados de ácido tetrámico para controlar nematodos
BRPI0821116A2 (pt) Composto, composição farmacêutica que o contem, uso deste e método para tratar qualquer mamífero afetado por câncer
PA8618401A1 (es) Prevencion y tratamiento de enfermedades cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1.3,5(10)-trien-3,16alfa-diol
DE602004025050D1 (de) Spinosyne für die wundheilung
WO2008057204A3 (en) Solid composition for treating water
UY29723A1 (es) Uso de arilanilidas para tratamiento de semillas
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
UY28812A1 (es) Agente parasiticida
ECSP088994A (es) INHIBIDORES DE CANAL DE POTASIO Kv1.5
DE60334533D1 (de) Gewebe-engineering

Legal Events

Date Code Title Description
FC Refusal